Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Neoplasms 18Breast Neoplasms 16Lung Neoplasms 10Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Melanoma 5Colorectal Neoplasms 5Brain Neoplasms 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Skin Neoplasms 3Myeloproliferative Disorders 3Leukemia, Myeloid, Acute 3Kidney Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Recurrence 2Neoplasm, Residual 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Lung Diseases 2Glioma 2Glioblastoma 2Genetic Predisposition to Disease 2Esophageal Neoplasms 2Endometrial Neoplasms 2

Interventions

Nivolumab 1Neurosurgical Procedures 1Ipilimumab 1Deamino Arginine Vasopressin 1Clinical Laboratory Techniques 1Blood Specimen Collection 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pituitary Neoplasms × Blood Specimen Collection × 90 days × Clear all
NCT03465618 2026-05-01

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
17 enrolled
CNSEndocrine

Brain Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡